142280 — Green Cross Medical Science Balance Sheet
0.000.00%
- KR₩79bn
- KR₩98bn
- KR₩108bn
Annual balance sheet for Green Cross Medical Science, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,843 | 10,751 | 5,744 | 678 | 373 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 21,623 | 20,807 | 21,364 | 17,858 | 21,059 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 52,351 | 50,137 | 43,345 | 39,429 | 40,749 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 40,013 | 41,158 | 42,850 | 45,054 | 44,181 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 95,629 | 96,471 | 90,529 | 87,975 | 90,510 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 48,870 | 39,488 | 46,528 | 37,123 | 35,392 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 59,514 | 63,216 | 56,030 | 46,760 | 46,151 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 36,115 | 33,255 | 34,499 | 41,214 | 44,359 |
| Total Liabilities & Shareholders' Equity | 95,629 | 96,471 | 90,529 | 87,975 | 90,510 |
| Total Common Shares Outstanding |